Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Wellness Center USA (OTCMKTS:WCUI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.
Profitability
This table compares Lipella Pharmaceuticals and Wellness Center USA’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lipella Pharmaceuticals | -817.16% | -172.07% | -141.17% |
| Wellness Center USA | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent ratings for Lipella Pharmaceuticals and Wellness Center USA, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lipella Pharmaceuticals | 0 | 0 | 1 | 0 | 3.00 |
| Wellness Center USA | 0 | 0 | 0 | 0 | 0.00 |
Valuation and Earnings
This table compares Lipella Pharmaceuticals and Wellness Center USA”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lipella Pharmaceuticals | $450,000.00 | 5.56 | -$4.62 million | ($0.60) | -0.52 |
| Wellness Center USA | $660,000.00 | 0.06 | -$750,000.00 | N/A | N/A |
Wellness Center USA has higher revenue and earnings than Lipella Pharmaceuticals.
Volatility and Risk
Lipella Pharmaceuticals has a beta of 0.31, meaning that its stock price is 69% less volatile than the S&P 500. Comparatively, Wellness Center USA has a beta of 1.86, meaning that its stock price is 86% more volatile than the S&P 500.
Insider and Institutional Ownership
74.3% of Lipella Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.0% of Wellness Center USA shares are owned by institutional investors. 37.0% of Lipella Pharmaceuticals shares are owned by insiders. Comparatively, 15.7% of Wellness Center USA shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
About Lipella Pharmaceuticals
Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.
About Wellness Center USA
Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.
Receive News & Ratings for Lipella Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lipella Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
